Introduction

MDPI

Email
chuyang.hen@mdpi.com

Bio
Dr. Márió Gajdács is currently a Senior Lecturer in the Department of Public Health, Albert Szent-Györgyi Faculty of Medicine at the University of Szeged. He received his pharmacy degree, Ph.D. (medical microbiology), board certification in “Pharmacology”, and “Non-clinical and clinical research” from the University of Szeged, and holds a Master in Public Health (MPH; specialization: epidemiology) and a Master of Healthcare Management from the University of Pécs. His research interests comprise the investigation of the influencing factors and facilitators of antimicrobial resistance (AMR) using epidemiological and social science methods; he is also interested in digital epidemiological/infodemiological studies, and other topics of public health importance. He published >180 publications in peer-reviewed journals.

Talk
Using Population-Level Digital Behavioral Signals to Inform Public Health and Health Promotion Initiatives Targeting Cancer-Related Disease Burden: A Hungarian Case Study

Bio
Prof. Gabriel Chodick is a senior faculty member at Tel Aviv University. He heads the Health Management graduate track at the School of Public Health and is in charge of the Tel Aviv–AstraZeneca Beam Research Center. Prof. Chodick was a co-founder of the KSM Research Institute (Maccabitech) at Maccabi Healthcare Services (MHS). He served as a board member of the Health Care Systems Research Network (HCSRN), a national organization of integrated health systems, and led MHS’s scientific research. He has published approximately 500 research articles, primarily in epidemiology and real-world data analytics.

Talk
From Big Data to Better Survivorship: Leveraging Real-World Evidence to Understand Long-Term Outcomes Among Childhood, Adolescent, and Young Adult (CAYA) Cancer Survivors

Bio
Dr. Samah Hayek is a senior lecturer in a tenure track position at the Department of Epidemiology and Preventive Medicine, School of Public Health, Faculty of Medical and Health Sciences, Tel Aviv University. Throughout her extensive academic tenure and research journey, she has cultivated a diverse array of multidisciplinary skills as an epidemiologist, biostatistician, and public health researcher. Focused on leveraging observational and clinical data, her work aims to furnish clinicians and healthcare professionals with tailored treatment guidelines for cancer patients, with a special emphasis on mitigating treatment toxicity through individualized medicine for cancer survivors. Recognizing the profound impact of understanding the genotype–phenotype relationship, she endeavors to enhance the overall health and longevity of cancer survivors. Her academic journey commenced with a Bachelor's degree in Statistics and Sociology from the University of Haifa, Israel, followed by a Master's degree in Epidemiology from the University of Haifa's School of Public Health. Her master's thesis, exploring second primary neoplasms among childhood cancer survivors, was subsequently published in Cancer Epidemiology. This scholarly pursuit led her to pursue a doctoral degree in public health with a focus on epidemiology at the University of Kentucky, generously funded by the Fulbright program. Post-doctorally, she embarked on a two-year tenure as a program evaluation fellow at the Centers for Disease Control and Prevention in Atlanta, GA. Subsequently, she undertook post-doctoral training at St. Jude Children’s Research Hospital, where her research focused on unraveling the complex interplay between cancer and aging phenotypes among adult survivors of childhood cancer. Since 2020, she has served as a senior researcher at the Clalit Research Institute, where she assumed a role as a principal investigator and collaborated on diverse research projects.